SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-20-153198
Filing Date
2020-05-27
Accepted
2020-05-27 17:01:49
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d936690d8k.htm 425 38950
2 EX-2.1 d936690dex21.htm EX-2.1 132944
3 EX-10.1 d936690dex101.htm EX-10.1 94619
4 EX-10.2 d936690dex102.htm EX-10.2 22347
5 EX-99.1 d936690dex991.htm EX-99.1 17576
6 GRAPHIC g936690g0527193036402.jpg GRAPHIC 5031
  Complete submission text file 0001193125-20-153198.txt   315021
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Subject) CIK: 0001373707 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-35837 | Film No.: 20916098
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filed by) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences